Statement: Mehmet Tolga Tuncel, Managing Director, Ataman Chemicals

CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.

In recent years, new business models and strategies provided by digitalization have also had to act together with new global economic imbalances. Aggressive policies of expanding geographical borders and trade of world countries are causing more polarization on Earth. Changing technology and the commercial pressure of new powerful warrior and producer countries on Europe and its immediate surroundings are essential factors in this recession.

The slowdown in regional production is causing economic activities to decline, and the decrease in business opportunities manifests as a significant recession in our region. As a chemical distributor company, we aim to spend this period thinking about long-term strategy, spending more time with our customers, and learning more. If we can spend the time we gain with total factor productivity listening to our customers’ demands, we can overcome the recession and competition.

Mehmet Tolga Tuncel, Ataman Chemicals © Ataman Chemicals
Mehmet Tolga Tuncel, Ataman Chemicals © Ataman Chemicals

“As a chemical distributor company, we aim to spend this period thinking about long-term strategy, spending more time with our customers, and learning more.”

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.